ContractAgreement • August 6th, 2020 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2020 Company IndustryCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE LINEAGE CELL THERAPEUTICS, INC. HAS DETERMINED THE INFORMATION: (A) IS NOT MATERIAL AND (B) WOULD LIKELY CAUSE COMPETITIVE HARM TO LINEAGE CELL THERAPEUTICS, INC. IF PUBLICLY DISCLOSED.
SECOND AMENDMENT TO CLINICAL TRIAL AND OPTION AGREEMENTTrial and Option Agreement • August 6th, 2020 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2020 Company IndustryCANCER RESEARCH UK a company limited by guarantee registered under number 4325234 and a charity registered under number 1089464 of 2 Redman Place, Stratford, London, E20 1JQ, England (the “Charity”);